Huimin Chen

Title: Innovations of Huimin Chen in Protein Kinase Research

Introduction

Huimin Chen is an accomplished inventor based in Bedford, MA (US). He has made significant contributions to the field of protein kinase research, particularly through his innovative patent related to a novel human protein kinase.

Latest Patents

Huimin Chen holds a patent for a composition employing a novel human kinase. This invention provides compositions, organisms, and methodologies that utilize a novel human protein kinase known as MCRK1. The novel human kinase exhibits sequence homology to rat myotonic dystrophy kinase-related Cdc42 binding kinase (MRCK) alpha. The gene encoding this novel kinase is localized in locus 11q13 of human chromosome 11. The protein kinase comprises multiple functional and structural domains, including a kinase domain, a pkinase_C domain, a DAG-PE binding domain, and a CNH domain. The sequence and structure similarity between the novel human protein and rat MRCK alpha suggest that this novel human protein may function as a downstream effector of Cdc42 in cytoskeleton reorganization.

Career Highlights

Huimin Chen is currently employed at Wyeth, where he continues to advance his research in protein kinases. His work has garnered attention for its potential applications in understanding cellular processes and disease mechanisms.

Collaborations

Some of Huimin Chen's notable coworkers include Wei Liu and Leeying Wu, who contribute to the collaborative research environment at Wyeth.

Conclusion

Huimin Chen's innovative work in the field of protein kinases exemplifies the impact of research on understanding complex biological systems. His contributions are paving the way for future advancements in this critical area of study.